Global High-Priority Regulatory Events — May 08, 2026

08-05-2026

Cellectar Biosciences entered into a registered direct offering and concurrent private placement on May 4, 2026, raising approximately $35 million in gross proceeds before fees, issuing 1,618,053 registered shares, 2,116,887 unregistered shares, pre-funded warrants for 9,471,086 shares, and milestone warrants for 13,206,026 shares each across three tranches, resulting in 7,975,069 shares outstanding post-closing (excluding warrants). Proceeds will fund working capital, general corporate purposes, and a planned Phase 3 trial of iopofosine I 131 for Waldenström macroglobulinemia. Separately, 12-month follow-up data from the Phase 2b CLOVER WaM trial reported strong efficacy with 83.6% ORR, 61.8% MRR, and 17.8 months median DoR in r/r WM patients.

• ·Milestone Warrants exercisable post-stockholder approval; exercise price $2.65 (institutional) or $2.88 (management); callable under specific clinical and stock price/volume conditions.
• ·Nantahala Capital Management entitled to designate one independent board member by June 5, 2026, subject to board approval.
• ·Registration Rights Agreement requires resale registration statement filed by May 19, 2026, effective within 60 days.
• ·Phase 2b subsets: BTKi-exposed (n=39) MRR 64.1%, DoR 18.2 months, PFS 15.9 months; BTKi-refractory (n=33) MRR 63.6%, DoR 18.2 months, PFS 14.8 months.
• ·Trial safety: transient AEs, no significant bleeding, infections <10%, cytopenias most common, non-hematologic toxicities mostly Grade <2.

08-05-2026

08-05-2026

Virtus Investment Partners, Inc. reported Q1 2026 total revenues of $199,535 thousand, down 8.4% YoY from $217,932 thousand, driven by lower investment management fees (down 9.1% to $169,133 thousand), leading to operating income of $15,448 thousand (down 57.8% YoY) and net income attributable to VRTS of $7,125 thousand ($1.07 basic EPS, down 74.0% from $4.12). While employment expenses decreased 3.6% to $105,213 thousand and operating cash flow improved to positive $35,901 thousand from negative $3,787 thousand, higher amortization ($15,175 thousand) and restructuring ($2,871 thousand) weighed on results. The company completed a $196,110 thousand business acquisition on March 1, 2026, adding $308,189 thousand in net assets, boosting total assets to $4,562,083 thousand (up 6.4% QoQ) and goodwill/intangibles significantly.

• ·Cash and cash equivalents decreased to $136,637 thousand from $386,483 thousand QoQ due to acquisition and dividends.
• ·Dividends declared at $2.40 per common share ($16,417 thousand).
• ·Common shares repurchased for $10,000 thousand.
• ·Contingent consideration increased to $126,316 thousand.
• ·Restructuring expense of $2,871 thousand in Q1 2026.

08-05-2026

CPS Technologies Corp. (NASDAQ:CPSH) announced Chris Fraser joined on May 4, 2026, to succeed retiring CFO Chuck Griffith, with Fraser assuming the CFO role on May 18, 2026, and Griffith's employment continuing through end of May for a smooth transition. President and CEO Brian Mackey praised Griffith's seven-year contributions and highlighted Fraser's relevant experience from Precision Castparts Corp. (Berkshire Hathaway subsidiary), Advanced Regenerative Manufacturing Institute, A.W. Chesterton, Oxford Instruments America, and Deloitte. The company focuses on advanced materials solutions including metal matrix composites, hermetic packaging, and HybridTech Armor® for sectors like aerospace, defense, and energy.

• ·Chris Fraser most recently led financial operations as Controller at Precision Castparts Corp. across three manufacturing plants for aerospace aluminum castings.
• ·Fraser previously served as Executive in Residence and CFO for early-stage ventures at Advanced Regenerative Manufacturing Institute funded by federal grants and SBIR programs.
• ·Fraser holds a Bachelor of Science in Economics from the University of Warwick, UK, and qualified as a chartered accountant at Deloitte in London.

08-05-2026

At the 2026 Annual Meeting of Stockholders held on May 7, 2026, Edwards Lifesciences Corporation stockholders elected all nine director nominees with strong majorities (For votes ranging from 428.7 million to 474.3 million shares), approved the advisory vote on named executive officer compensation (424.96 million For vs. 50.92 million Against), ratified PricewaterhouseCoopers LLP as independent auditors for FY2026 (446.28 million For vs. 56.81 million Against), and approved the amendment to the Long-Term Stock Incentive Compensation Program increasing available shares by 7,000,000 to a total of 341,500,000 shares. All proposals passed with overwhelming support exceeding 88%, indicating strong shareholder alignment. No proposals failed or faced significant opposition.

• ·Paul A. LaViolette received the lowest For votes (428,701,646) and highest Against (45,445,276) among directors
• ·Steven R. Loranger had 28,909,945 Against votes
• ·Exhibit 10.1: Full text of Amended and Restated Long-Term Stock Incentive Compensation Program
• ·Meeting results filed as part of 8-K on May 8, 2026

08-05-2026

NextTrip, Inc. adopted a Certificate of Designation via unanimous written consent of the Board on December 4, 2025, authorizing 450,000 shares of Series B Convertible Preferred Stock with a Stated Value and Fixed Conversion Price of $2.755 per share, pursuant to a Securities Purchase Agreement dated May 6, 2026. The preferred stock provides for dividends accruing on the Stated Value, a liquidation preference of 115% of Stated Value plus accrued dividends, certain protective voting rights for holders, and mandatory redemption on August 30, 2026. No operational performance metrics are reported; the issuance may lead to dilution upon conversion to common stock.

• ·Board resolution adopted via unanimous written consent on December 4, 2025.
• ·Securities Purchase Agreement dated May 6, 2026.
• ·Mandatory Redemption Date: August 30, 2026 (extendable at Holder option).
• ·Multiple Events of Default defined, including failure to maintain DTC eligibility, share reservation, or timely SEC filings.
• ·Holders require majority consent for adverse changes to terms, further Series B issuance, or certain low-price share sales.

08-05-2026

Smith Micro Software, Inc. filed an S-1 registration statement on May 8, 2026, to register 18,224,625 shares of common stock for resale by selling stockholders, primarily underlying warrants from recent debt and equity offerings that raised approximately $9.75 million in gross proceeds since September 2025. While the company secured extensions from Nasdaq until June 22, 2026, to regain compliance with the $1.00 minimum bid price requirement, it faces delisting risks and potential reverse stock split, which could adversely impact market capitalization. Executive appointments include William W. Smith Jr. as Executive Chairman, Timothy C. Huffmyer as President and CEO, and Bethany M. Braund as CFO, effective March 31, 2026.

• ·Nasdaq compliance period extended to June 22, 2026; requires $1.00 closing bid price for 10 consecutive business days.
• ·September warrants exercise price adjustable to $0.6708 per share pending stockholder approval at May 26, 2026 annual meeting.
• ·March convertible notes payable in monthly installments of ~$7,000 per $1,000,000 principal starting May 1, 2026; convertible after 6 months at $0.68 per share.
• ·Company considering reverse stock split to regain Nasdaq compliance, but no assurance of success and potential market capitalization reduction.

08-05-2026

Apollo Realty Income Solutions, Inc. reported total revenues of $16,450 for Q1 2026, up 163% YoY from $6,261, primarily driven by rental revenue growth to $16,450 from $6,261. However, net income declined 5.6% YoY to $14,666 from $15,531 due to higher total expenses of $17,220 (up 106% YoY) and increased interest expense of $7,270 (up 105% YoY), with net income per share dropping to $0.20 from $0.28. Total assets grew 1.8% QoQ to $2,118,198 as of March 31, 2026 from $2,081,151 at year-end 2025, while investments in real estate debt decreased slightly to $1,189,658 from $1,206,847.

• ·Net cash provided by operating activities increased 30% YoY to $25,370 from $19,541.
• ·Net cash used in investing activities improved to $11,938 outflow from $187,886 outflow YoY.
• ·Common stock repurchases totaled $17,358 in Q1 2026.
• ·Distributions declared on common stock were $19,784 in Q1 2026.

08-05-2026

For Q1 2026 ended March 31, Watsco reported revenues of $1,533,010 thousand, up a negligible 0.1% YoY from $1,531,086 thousand, while gross profit declined 0.5% to $427,555 thousand, operating income fell 1.8% to $110,184 thousand, and net income attributable to Watsco dropped 1.3% to $79,074 thousand (EPS $1.87 vs $1.93). Balance sheet reflected a 24% QoQ surge in inventories to $1,715,195 thousand amid a 9% drop in cash to $392,679 thousand and total assets up 5% to $4,649,497 thousand. Cash flow from operations improved to a lesser use of $18,905 thousand from $177,644 thousand, driven by working capital changes, though offset by $121,775 thousand in dividends.

• ·Foreign currency translation adjustment: $(4,925) thousand Q1 2026 vs $248 thousand Q1 2025.
• ·Accounts payable up 68% QoQ to $587,417 thousand.
• ·Net cash provided by investing activities: $93,138 thousand Q1 2026 vs $244,556 thousand Q1 2025.
• ·Dividends declared and paid: $3.00 per share on common stock.
• ·Non-controlling interest net income: $13,867 thousand Q1 2026 (down from $14,479 thousand).

08-05-2026

Quadrant Televentures Limited, under Corporate Insolvency Resolution Process (CIRP) since NCLT order dated September 2, 2025, held its Eighth Committee of Creditors (CoC) meeting on April 22, 2026, with all resolutions approved at 66.17% voting, exceeding required thresholds. Approvals include extending the resolution plan submission deadline to May 16, 2026, refunding EOI deposit to one prospective applicant, disposal of equity shares by secured lenders, appointment of a professional, CIRP cost approval, and ratification of short notice period. The ongoing delays in resolution highlight persistent insolvency challenges with no finalized plan yet.

• ·CIRP initiated by NCLT order dated September 2, 2025
• ·Eighth CoC meeting convened on April 22, 2026 with e-voting per Regulation 26 of CIRP Regulations
• ·Voting thresholds: 51% for most items, 66% for equity disposal (Item 8)

08-05-2026

The Committee of Independent Directors of Shah Foods Limited met on May 08, 2026, and concluded that the open offer by Acquirers Ankit Jalan and Anuj Jalan, along with PACs including Jalan Sarees Private Limited, to acquire up to 60,61,900 equity shares (26.00% of equity share capital) at ₹62.50 per fully paid-up share of ₹10 face value is fair and reasonable. This follows the Public Announcement dated February 10, 2026, Detailed Public Statement dated February 16, 2026 (published February 17), and Letter of Offer dated April 29, 2026.

• ·Ankit Jalan HUF (PAC-5)
• ·Anuj Jalan HUF (PAC-6)
• ·BSE Code: 519031
• ·Registered Office: 301, Sarthik Square, Nr. Shapath – 3, S. G. Highway, Bodakdev, Ahmedabad – 380054, Gujarat, India

08-05-2026

Kallam Textiles Limited (formerly Kallam Spinning Mills Limited) has initiated the Corporate Insolvency Resolution Process (CIRP) with Form G published on May 08, 2026, inviting Expressions of Interest under Regulation 36A(1) of the Insolvency and Bankruptcy Regulations, 2016. The advertisement by Resolution Professional Rajesh Chillale appeared in Financial Express (All India editions), Prajashakthi (All AP editions), and Mana Telangana (All Telangana editions). This development signals significant financial distress for the company.

• ·CIN: L18100AP1992PLC013860
• ·Scrip Code: 530201 (BSE)
• ·RP Registration: IBBI/IPA-001/IP-P00699/2017-2018/11226
• ·RP Email: ktl.cirp@gmail.com
• ·Publication weblinks: Financial Express (https://epaper.financialexpress.com/4149323/Hyderabad/May-08-2026#page/25/2), Mana Telangana (https://epaper.manatelangana.news/4149256/HYDERABAD/08‐05‐2026#page/12/2), Prajashakthi (https://epaper.prajasakti.com/view/?date=2026-05-08&edition=1&pg_no=3)

08-05-2026

Jindal Poly Films Limited disclosed under Regulation 30 of SEBI LODR that the NCLT Principal Bench, New Delhi, in a hearing on May 7, 2026, allowed substitution of M/s Monet Securities Pvt Ltd as lead applicant in Company Petition No 58/245/PB/2024, filed by minority shareholders Mr. Ankit Jain & Ors., after the original lead applicant and two co-applicants exited. The company states this change has no implications on the merits of the case and is yet to receive the order copy. No financial implications or penalties are mentioned, and the company is examining the directions for appropriate action.

• ·Petition details: Company Petition No 58/245/PB/2024
• ·Continuation of earlier disclosure dated April 10, 2026
• ·NSE Symbol: JINDALPOLY; BSE Scrip Code: 500227
• ·CIN: L17111UP1974PLC003979

08-05-2026

Garware Technical Fibres Limited's board approved a buyback of up to 1,617,500 fully paid-up equity shares (1.63% of total paid-up equity share capital) at ₹680 per share for an aggregate amount not exceeding ₹110 Cr via the tender offer route using the stock exchange mechanism. This represents 9.46% and 9.35% of the company's aggregate fully paid-up equity share capital and free reserves per latest audited standalone and consolidated financials as of March 31, 2025. Promoters and promoter group have expressed their intention not to participate; record date is May 20, 2026.

• ·Board may increase buyback price and decrease number of shares up to one working day prior to record date without changing buyback size.
• ·Buyback Committee constituted to handle execution.
• ·Pre-buyback shareholding: Foreign Investors 10.73%, Financial Institutions/Banks & MFs 10.28%, Others 25.63%.
• ·Board meeting held on May 08, 2026 from 12:30 pm to 2:30 pm.

08-05-2026

AGI Greenpac Limited informed BSE and NSE on May 8, 2026, about completing circulation of Postal Ballot Notice via email on May 7, 2026, to members as on the May 1, 2026 cut-off date, in compliance with Companies Act and SEBI regulations. Advertisements were published on May 8, 2026, in Financial Express (English) and Ek din (regional). The ballot seeks shareholder approval via remote e-voting for increasing authorized share capital (ordinary resolution) and issuing equity warrants on preferential basis (special resolution), with Ms. Rachana Shanbhag appointed as scrutinizer.

• ·Cut-off date for members: May 1, 2026
• ·Remote e-voting commencement: May 8, 2026
• ·Remote e-voting conclusion: June 6, 2026
• ·Newspapers for advertisement: Financial Express (English), Ek din (Regional)

08-05-2026

The Committee of Independent Directors (IDC) of AVI Products India Limited unanimously recommends the open offer by PPMS Real Estates LLP to acquire up to 8,59,769 fully paid-up equity shares (26.00% of voting share capital, face value ₹10 each) at ₹33.00 per share as fair and reasonable, stating it exceeds the highest price among selective criteria under SEBI (SAST) Regulations, 2011. The recommendation follows review of the Public Announcement (Feb 14, 2026), Detailed Public Statement (Feb 23, 2026), and Letter of Offer (May 02, 2026). Public shareholders are advised to independently evaluate the offer.

• ·IDC meeting held on May 07, 2026; filing dated May 08, 2026
• ·IDC members have no equity holdings, contracts, relationships with Target Company or Acquirer, and no trading in shares during relevant periods

08-05-2026

Prime Focus Limited disclosed an update on its appeal before the NCLAT against the NCLT Mumbai Bench's oral pronouncement on May 6, 2026, admitting a petition under Section 7 of the IBC, leading to CIRP initiation. On May 8, 2026, NCLAT directed the IRP not to take further steps pursuant to the NCLT order, with the next hearing scheduled for May 11, 2026. This represents ongoing uncertainty in insolvency proceedings with no resolution yet.

• ·Appeal details: Comp. App. (AT) (Ins.) 850 of 2026 before Hon’ble NCLAT, New Delhi
• ·Scrip codes: BSE: 532748 / NSE: PFOCUS
• ·Disclosure under Regulation 30 of LODR Regulations

08-05-2026

Camlin Fine Sciences Limited disclosed the results of a postal ballot on May 8, 2026, where members approved an ordinary resolution to increase the Authorized Share Capital and amend Clause V of the Memorandum of Association with near-unanimous support (99.9899% votes in favor out of 57.8993% polled on 192,091,613 outstanding shares). Promoters and promoter group voted 100% in favor with full participation, while public institutions also voted 100% in favor (83.33% polled), and public non-institutions showed 99.77% in favor (6.01% polled) with negligible opposition (0.0101%). No significant opposition or abstentions were noted.

• ·Cut-off date for shareholders: April 3, 2026
• ·Postal ballot voting period: April 8, 2026 (9:00 a.m. IST) to May 7, 2026 (5:00 p.m. IST)
• ·Scrutinizer's Report dated May 8, 2026; available on company website https://www.camlinfs.com/

08-05-2026

UR-Energy Inc reported Q1 2026 results with first-ever sales of $3.9M and gross profit of $1.2M, a significant improvement from a $2.6M gross loss in Q1 2025. However, operating loss widened to $20.3M from $15.8M YoY due to higher development ($14.9M vs $9.7M) and exploration costs, driving net loss to $28.8M from $10.9M. Total assets increased 7% QoQ to $291.6M and shareholders' equity rose to $82.9M from $77.5M, bolstered by $33.1M from warrant exercises, though operating cash flow turned to a $16.5M use from $2.8M provided YoY.

• ·Capital assets increased to $61.2M from $49.7M QoQ, with purchases of $12.3M.
• ·Long-term debt at $67.6M as of March 31, 2026.
• ·Proceeds from exercise of warrants and stock options: $28.7M in Q1 2026.

08-05-2026

Cloudflare reported Q1 2026 revenue of $639,755 up 33.5% YoY from $479,087, driven by balanced growth across regions including US at 49% of revenue (+34.5%) and EMEA at 28% (+31.3%), with gross profit rising 25.3% to $455,597. However, operating expenses increased 24.2% to $517,591 due to higher sales and marketing (+26.9%), R&D (+31.0%), and G&A (+8.4%), resulting in a wider operating loss of $61,994 versus $53,247 YoY and a net loss of $22,927 despite improvement from $38,454. Cash flow from operations grew 8.7% to $158,330, while total assets expanded QoQ to $6,163,977 from $6,036,256 but cash equivalents dipped to $932,226 from $943,536.

• ·Deferred revenue increased to $755,097 (current) from $684,207 QoQ.
• ·Stock-based compensation expense was $117,922 in Q1 2026 versus $98,403 in Q1 2025.
• ·US revenue $315,830 (49% of total), EMEA $175,678 (28%), Asia Pacific $98,648 (15%), Other $49,599 (8%) in Q1 2026.
• ·Net cash used in investing activities $158,806 in Q1 2026, up from $92,438 YoY.

08-05-2026

Astrana Health reported strong Q1 2026 results with total revenue surging 56% YoY to $965,100 from $620,390, driven by capitation net up 53% to $892,908, Medicare revenue up 56% to $608,116, and Medicaid up 32% to $228,572; net income attributable to Astrana rose 116% to $14,436. However, risk pool settlements and incentives declined 14% to $12,486, interest expense more than doubled to $16,101, and total other expense net remained negative at $8,819 though improved from $10,979 prior year. Cash from operations improved dramatically to $68,056 from $16,627.

• ·Earnings per share – diluted Q1 2026: $0.29 vs $0.14 Q1 2025.
• ·Total current assets increased to $1,004,100 from $863,313 QoQ.
• ·Long-term debt decreased slightly to $979,764 from $990,904 QoQ.
• ·Share-based compensation expense: $9,895 in Q1 2026 vs $7,811 Q1 2025.

08-05-2026

Yum China Holdings, Inc. reported total revenues of $3,271 million for Q1 2026, up 9.7% YoY from $2,981 million, driven by company sales growth to $3,047 million (+8.8%). Operating profit increased 12.0% to $447 million and net income attributable to Yum China rose to $309 million (+5.8%), with diluted EPS at $0.87 (+13.0%). However, net interest income declined to $16 million from $26 million, investment resulted in a $11 million loss versus a $3 million gain, and cash & equivalents ended at $473 million after a $33 million net decrease.

• ·KFC segment revenues $2,453 million; Pizza Hut $635 million in Q1 2026.
• ·Share repurchases totaled $218 million in Q1 2026, reducing outstanding shares to 351 million.
• ·Total assets increased slightly to $10,837 million as of March 31, 2026 from $10,783 million at year-end 2025.
• ·Net cash used in financing activities $353 million in Q1 2026.
• ·Capital spending $144 million in Q1 2026.

08-05-2026

Gale Klappa completed his service as Chairman of the Board of WEC Energy Group, Inc. on May 7, 2026, after reaching the applicable retirement age under the company's Corporate Governance Guidelines. In recognition of his service, the Compensation Committee approved the acceleration of vesting for approximately 1,616 unvested shares of restricted stock awarded to Mr. Klappa, effective May 7, 2026.

• ·Approval by Compensation Committee on May 4, 2026
• ·Event reported under Item 5.02 of Form 8-K

08-05-2026

New Horizon Aircraft Ltd. announced the pricing of a $20 million offering of 9,254,889 Class A Ordinary Shares to institutional investors, with closing expected on or about May 8, 2026. Gross proceeds will fund and accelerate the Cavorite X7 aircraft program, working capital, and general corporate purposes. CEO Brandon Robinson highlighted the financing as a milestone expanding the institutional shareholder base and supporting commercialization.

• ·Shelf registration statement on Form S-3 filed February 14, 2025, effective March 25, 2025.
• ·Titan Partners acting as sole placement agent.

08-05-2026

On May 6, 2026, Medical Exercise Inc. entered into a Franchise Agreement with Degco Fitness Ventures Ltd., granting rights to own and operate the first OnCore Longevity Center franchise in Regina, Saskatchewan, Canada. This agreement represents the company's initial expansion into the Canadian market and the commencement of its franchise-based revenue model, deemed material by management. The company issued a press release announcing the agreement, incorporated as Exhibit 99.1.

• ·Agreement executed on May 6, 2026; filing dated May 8, 2026.
• ·Company is an emerging growth company.
• ·Principal executive offices: Suite 300, 7901 4th Street North, St. Petersburg, FL 33702.

08-05-2026

On May 6, 2026, Amprius Technologies, Inc. entered into Warrant Exchange Agreements with certain institutional holders to exchange an aggregate of 7,128,458 public warrants (exercisable at $11.50 per share) for shares of common stock, based on a formula incorporating the average VWAP over a four-day period plus $0.35 minus the exercise price. The transaction relies on Section 4(a)(2) of the Securities Act for unregistered issuance and is expected to close on May 18, 2026, subject to customary conditions. No financial performance metrics or period-over-period comparisons are disclosed in the filing.

• ·Exchange Shares issuance in reliance on Section 4(a)(2) of the Securities Act; shares may not be re-offered or sold absent registration or exemption.
• ·Securities traded on The New York Stock Exchange.
• ·Company qualifies as an emerging growth company.

08-05-2026

Quetta Acquisition Corporation (QETAR) entered into a Release and Discharge of Promissory Notes with KM Quad, effective April 30, 2026, fully releasing the company from $1,040,000 in principal obligations under three promissory notes issued in 2024 and 2025. This release settles all related claims, interest, and fees in connection with a Termination Agreement dated January 15, 2026, that ended a prior transaction, providing the company with liability certainty and improved balance sheet flexibility. No further payments are due under the notes.

• ·Notes terminated in their entirety with no further force or effect.
• ·Release governed by New York law and executed in counterparts.

08-05-2026

Signet Jewelers appointed Jeffrey Gennette, former Chairman and CEO of Macy’s, Inc., to its Board effective May 6, 2026, expanding it to 12 directors; he joins the Human Capital Management & Compensation Committee and Finance Committee to support strategy execution. Director Nancy Reardon, who has served since March 2018, will not stand for re-election at the Annual General Meeting on June 26, 2026, reducing the board to 11 members following her departure.

• ·Gennette's experience: CEO of Macy’s from March 2017 to February 2024; Chairman from February 2018 to April 2024; over 40 years in retail.
• ·Reardon served as Chair of Human Capital Management & Compensation Committee.
• ·Investor contact: robert.ballew@signetjewelers.com; Media: katie.spencer@signetjewelers.com.

08-05-2026

DXC Technology's FY2026 revenues declined 1.8% YoY to $12,644 million from $12,871 million, with significant drops in the US market (-9.9%) and GIS segment (-3.9%), partially offset by growth in Insurance (+5.4%), Other Europe (+2.9%), and slight increases in UK (+2.5%) and Other International (+0.5%). Net income attributable to common stockholders plummeted to $18 million ($0.10 diluted EPS) from $389 million ($2.10 diluted EPS), driven by higher income tax expense ($290 million vs $234 million) and pension losses. Non-GAAP net income was $577 million ($3.23 diluted EPS), down from $634 million ($3.43), reflecting ongoing challenges despite cost reductions in areas like restructuring (-24.8%) and interest expense (-18.5%).

• ·Costs of services decreased $157 million (-1.6%) to $9,613 million.
• ·Selling, general and administrative increased $54 million (+4.0%) to $1,402 million.
• ·Depreciation and amortization declined $127 million (-9.9%) to $1,160 million.
• ·Restructuring costs fell $38 million (-24.8%) to $115 million.
• ·Organic revenue growth was -4.8% in FY2026.
• ·Effective tax rate rose to 91.2% from 37.1%.

08-05-2026

Republic Services, Inc. reported Q1 2026 revenue of $4,113 million, up 2.6% YoY from $4,009 million, driven by modest volume and pricing gains, while operating income rose 3.2% to $830 million. Net income increased 6.1% to $525 million ($1.70 diluted EPS, up 7.6% from $1.58), supported by strong operating cash flow of $1,227 million (up 19.7% YoY). However, losses from unconsolidated equity method investments widened to $52 million from $12 million, interest expense grew 7.9% to $151 million, and revenue growth remained modest amid higher cost of operations.

• ·Acquisitions total purchase price $433 million in Q1 2026 vs $826 million in Q1 2025, with goodwill of $218 million vs $598 million.
• ·Capital expenditures (purchases of property and equipment) $476 million in Q1 2026 vs $459 million in Q1 2025.
• ·Treasury stock purchases $317 million in Q1 2026 vs $55 million in Q1 2025.
• ·Cash dividends declared per share $0.625 in Q1 2026 vs $0.580 in Q1 2025.
• ·Total stockholders' equity $11,981 million as of March 31, 2026 vs $11,969 million as of December 31, 2025.

08-05-2026

IREN Ltd's total assets surged to $7,265M as of March 31, 2026 from $2,940M at June 30, 2025, bolstered by $2.6B in equity issuances and property, plant & equipment rising to $4,370M. For Q3 FY2026 (three months ended March 31), total revenue remained flat YoY at $145M, with Bitcoin mining revenue declining 21% to $111M offset by AI Cloud Services exploding 839% to $34M, but a $248M net loss emerged due to $140M impairments, $121M depreciation, and operating loss of $234M. Over nine months FY2026, revenue grew 82% YoY to $570M with net loss narrowing to $19M from $90M, though marred by $188M impairments and $321M SG&A expenses.

• ·Property, plant and equipment, net increased to $4,370M from $1,931M.
• ·Convertible notes payable rose to $3,688M from $963M.
• ·SG&A expenses for nine months FY2026: $321M, up 286% YoY.
• ·Depreciation and amortization Q3 FY2026: $121M.
• ·Unrealized gain on financial instruments nine months FY2026: $534M.

08-05-2026

McKesson Corporation reported revenues of $403,430 million for the year ended March 31, 2026, up 12% from $359,051 million in 2025, with strong growth in Oncology & Multispecialty (+31%) and North American Pharmaceutical (+11%), driving net income to $5,099 million (+46%) and diluted EPS to $38.38 (+49%). However, gross profit margin declined 10 basis points to 3.61%, Medical-Surgical Solutions revenue grew only 1%, Other segment revenue fell 4%, and net cash decreased by $1,888 million compared to a $1,371 million increase prior year amid higher investing outflows.

• ·Days outstanding flat at 22 for customer receivables, 24 for inventories, and up to 59 for drafts and accounts payable.
• ·Corporate expenses, net increased 17% to $931 million.
• ·Total debt $6,526 million with debt to capital ratio at 128.0%.
• ·Restructuring, impairment, and related charges, net down 14% to $245 million.

08-05-2026

SHARING ECONOMY INTERNATIONAL INC. reported no revenues for the second consecutive year ended December 31, 2025, with a reduced net loss of $24,388 compared to $85,528 in 2024 due to lower operating expenses of $24,383 versus $69,251. Cash and cash equivalents increased significantly to $263,147 from $1,554, supported by $266,768 in financing activities, while total assets rose slightly to $18,320,261. However, total liabilities grew 7.11% to $4,260,812 and stockholders' equity declined 0.2% to $14,059,449.

• ·Net Cash Used in Operating Activities improved to $(24,388) from $(85,528).
• ·Net Cash Provided by Financing Activities increased to $266,768 from $36,852.
• ·Effect of Exchange Rate Changes in Cash: $19,213 in 2025 vs. $48,673 in 2024.

08-05-2026

For Q1 2026, Nu Skin Enterprises reported revenue of $320,608 down 12.1% YoY from $364,490, with gross profit declining 13.2% to $214,463 amid higher cost of sales pressures. Operating income improved to $4,026 from a $9,903 loss, driven by sharply lower operating expenses ($210,437 vs $256,864), but net income fell 98.3% to $1,836 due to the absence of the prior year's $176,162 gain on sale of business. Cash and equivalents decreased to $198,654 from $238,630 at year-end, with operating cash used of $3,919.

• ·Impairment expenses decreased to $1,839 from $25,114 YoY.
• ·Stockholders' equity declined to $794,087 from $805,240 QoQ.
• ·Net cash used in operating activities $3,919 vs provided $389 YoY.

08-05-2026

NewLake Capital Partners, Inc. reported Q1 2026 total revenue of $12,309 thousand, down 7% YoY from $13,209 thousand, driven by a 7% decline in rental income to $11,763 thousand, while fees and reimbursables fell 16%. Net income attributable to common stockholders decreased 8% YoY to $5,775 thousand or $0.28 per basic share from $6,297 thousand or $0.31 per share, though total expenses declined 6% to $6,306 thousand and net cash from operating activities rose 2% to $10,394 thousand. Total assets stood at $417,631 thousand as of March 31, 2026, down 1% QoQ from $420,829 thousand.

• ·Three vacant properties: Nevada Cultivation ($12,158 thousand net), Pennsylvania Cultivation ($13,712 thousand net), Massachusetts Cultivation ($37,070 thousand net).
• ·Loan Receivable net of $4,940 thousand with Current Expected Credit Loss of $60 thousand as of March 31, 2026.
• ·Revolving Credit Facility balance unchanged at $7,600 thousand.

08-05-2026

Inseego Corp. reported Q1 2026 total revenues of $34,338 (up 8.5% YoY from $31,673), driven by Fixed wireless access solutions surging 179% to $5,314 and Product revenues rising 12% to $22,002, though Mobile solutions declined 6% to $16,688. Operating loss widened to $3,566 from $424 YoY due to operating expenses increasing 31% to $20,163, primarily from higher R&D (+28%), Sales & marketing (+43%), and G&A (+54%). Cash and equivalents fell 22.5% QoQ to $19,297, but operating cash flow improved to positive $1,715 from $(3,467); net income attributable to common stockholders was $10,564 due to a $15,100 preferred stock exchange deemed contribution.

• ·Preferred stock fully exchanged: 25,000 shares redeemed for 767,000 common shares, with $41,966 carrying value removed and $23,532 fair value of consideration issued.
• ·2029 Senior Secured Notes increased to $50,415 from $41,611 QoQ.
• ·Stockholders’ deficit deepened to $(25,415) from $(4,044) QoQ.
• ·Inventories rose 62% QoQ to $12,541.
• ·Operating cash flows from continuing operations: $1,715 (Q1 2026) vs $(3,467) (Q1 2025).

08-05-2026

For Q1 2026, CMCT reported total revenues of $29,417, down 9% YoY from $32,295, driven by declines in rental and other property income to $16,298 (from $17,220) and hotel income to $11,877 (from $12,134), while total expenses rose to $38,195 from $37,295, widening net loss to $8,417 from $6,272. Net loss attributable to common stockholders ballooned to $34,695 from $11,898 due to $22,206 in preferred stock redemptions paid in common stock. However, the company generated $41,438 in investing cash flows from $44,630 proceeds on asset sales (including First Western gain of $1,737), reducing debt by $9,690 QoQ to $500,078 and total assets to $792,321 from $859,187.

• ·Operating cash flow shifted to a use of $25,991 in Q1 2026 from provision of $1,208 in Q1 2025, primarily due to $20,440 decrease in due to related parties.
• ·Weighted average common shares outstanding: 492 basic/diluted in Q1 2026 vs 6 in Q1 2025.
• ·Loss per common share: $(70.52) basic/diluted Q1 2026 vs $(1,983.00) Q1 2025.
• ·Redeemable preferred stock dividends declared or accumulated: $4,180 Q1 2026 vs $5,484 Q1 2025.

08-05-2026

Monster Beverage Corp reported strong Q1 2026 results with net sales up 26.9% YoY to $2,353,291 thousand from $1,854,558 thousand, gross profit up 23.5% to $1,293,349 thousand, and net income up 28.6% to $569,485 thousand. Operating income rose 28.2% YoY to $729,958 thousand despite higher operating expenses up 17.8%. However, cash and cash equivalents decreased QoQ by 2.3% to $2,039,700 thousand from $2,088,117 thousand, and property and equipment net declined slightly to $1,074,598 thousand from $1,081,544 thousand.

• ·Stock repurchases of $133,970 thousand in Q1 2026 vs $16,633 thousand in Q1 2025.
• ·Net cash used in investing activities $520,685 thousand in Q1 2026 primarily due to purchases of available-for-sale investments.
• ·Comprehensive income $560,990 thousand in Q1 2026 vs $509,534 thousand in Q1 2025, impacted by other comprehensive loss of $8,495 thousand.

08-05-2026

Ameren Corporation's consolidated net income rose 23% YoY to $358 million in Q1 2026 from $290 million, supported by improved operating income in subsidiaries such as $109 million (up 70% YoY) in one segment and $386 million (up 14% YoY) in another. However, net cash provided by operating activities declined slightly by 2% to $421 million from $431 million YoY, operating revenues in one segment fell 3% to $930 million, and capital expenditures surged 48% to $1,574 million. Total assets grew 3% QoQ to $49,846 million as of March 31, 2026.

• ·Dividends per common share increased to $0.75 from $0.71 YoY.
• ·Common stock shares outstanding at 276.7 million as of March 31, 2026, up slightly from 276.4 million at year-start.
• ·Short-term debt net increase of $534 million in Q1 2026 financing activities.

08-05-2026

For the nine months ended March 31, 2026, InnovAge Holding Corp. reported total revenues of $727,756 up 15.1% YoY from $632,282, primarily driven by 15.1% growth in capitation revenue to $726,873, while other service revenue declined slightly. However, the three-month operating loss widened to $(29,079) from $(10,158), a 186% deterioration due to corporate, general and administrative expenses surging to $76,531 from $38,597; nine-month operating loss improved to $(7,528) from $(27,611). Net cash provided by operating activities rose sharply 82% to $43,425, increasing cash and equivalents to $95,536 from $64,129 at June 30, 2025.

• ·Corporate, general and administrative expenses three months: $76,531 (up 98% YoY from $38,597)
• ·Total liabilities increased to $288,500 from $263,943
• ·Stockholders’ equity declined to $232,779 from $237,898
• ·Long-term debt, net reduced to $55,432 from $57,464
• ·Property and equipment, net: $165,352 (down from $168,044)

08-05-2026

Sweetgreen reported Q1 FY26 revenue of $161.5M, down 2.9% YoY from $166.3M, driven by an 18.6% increase in Owned Digital Channels to $62.8M but offset by a 20.6% decline in In-Store Channel to $53.0M and a 1.9% drop in Marketplace Channel. Operating loss widened to $34.3M from $28.5M due to higher restaurant costs, but net income swung to a $125.8M profit from a $25.0M loss, primarily from a $160.6M gain on disposal of the Spyce business which generated $100M in cash proceeds. Cash and equivalents rose to $156.8M from $89.2M QoQ, supported by the sale.

• ·Net cash used in operating activities increased to $17.2M from $13.1M YoY.
• ·Stock-based compensation expense declined to $5.8M from $10.2M YoY.
• ·General and administrative expenses decreased 23.7% YoY to $29.3M.

08-05-2026

Natera reported Q1 2026 total revenues of $696.6M, up 38.8% YoY from $501.8M, driven by product revenues increasing 38.7% to $693.9M primarily from insurance carriers. However, net loss widened 27.1% YoY to $85.1M from $66.9M due to sharply higher R&D expenses (up 63.2%) and SG&A (up 22.9%), while cash provided by operating activities declined 9.6% to $40.2M. Balance sheet strengthened QoQ with total assets at $2.61B (up 9.0%) and cash at $1.09B (up 1.1%).

• ·Accounts receivable increased QoQ to $417.6M from $296.5M, contributing to lower operating cash flow.
• ·Total Foresight Diagnostics acquisition consideration was $424.5M, including $273.0M in common stock and $118.4M contingent consideration.
• ·Stock-based compensation expense was $94.1M in Q1 2026, up from $78.4M YoY.
• ·$10M investment in related party during Q1 2026.

08-05-2026

Vistra Corp. reported robust Q1 2026 results with operating revenues of $5,640 million, up 43% YoY from $3,933 million, driving operating income to $1,499 million from a $120 million loss and net income attributable to Vistra of $1,029 million ($2.90 basic EPS) versus a $268 million loss (-$0.93 EPS). Operating cash flow improved to $1,199 million from $599 million. However, cash and equivalents fell to $634 million from $785 million at year-end 2025 amid $883 million in capital expenditures and $372 million in stock repurchases, with total cash flow negative at $145 million.

• ·Long-term debt increased to $17,264 million from $15,842 million QoQ.
• ·Short-term borrowings reduced to $0 from $1,800 million QoQ.
• ·Stock repurchases totaled $372 million, increasing treasury stock to $7,303 million.
• ·Capital expenditures, including nuclear fuel, were $883 million.

08-05-2026

For Q1 2026, Community West Bancshares reported net income of $11,489 thousand, up 38.5% YoY from $8,293 thousand, driven by net interest income growth of 11.9% to $36,003 thousand and lower interest expense of $11,889 thousand (down 8.2%). However, provision for credit losses shifted to a $90 thousand charge from a $41 thousand credit, non-interest expenses declined only 2.0% to $22,987 thousand, and other comprehensive loss was $211 thousand versus $2,355 thousand income prior year amid persistent unrealized losses on securities. Shareholders' equity reached $419,203 thousand, up from $372,197 thousand YoY, while cash equivalents fell to $130,326 thousand from $148,392 thousand.

• ·Basic EPS $0.60 in Q1 2026 vs $0.44 in Q1 2025.
• ·Cash dividend per common share remained flat at $0.12.
• ·Net cash from operating activities $10,922 thousand vs $11,067 thousand (flat, down 1.3%).
• ·Net cash used in investing activities $4,417 thousand vs provided $804 thousand.
• ·Significant FHLB borrowings $1,215,000 thousand and repayments $1,254,000 thousand in Q1 2026.
• ·AFS securities estimated fair value $467,871 thousand at March 31, 2026, with gross unrealized losses $40,901 thousand.

08-05-2026

Ocugen, Inc. reported Q1 2026 collaborative arrangement revenue of $1,533 thousand, up 3.5% YoY from $1,481 thousand, but total operating expenses increased 21.3% to $19,372 thousand, resulting in a wider net loss of $19,177 thousand versus $15,350 thousand in Q1 2025. Cash and equivalents rose 71.6% QoQ to $31,855 thousand from $18,571 thousand at December 31, 2025, driven by $34,984 thousand in net financing inflows primarily from common stock issuances and warrant exercises, flipping stockholders' equity to a positive $5,805 thousand from a $12,166 thousand deficit. Operating cash use worsened to $21,794 thousand from $19,357 thousand YoY.

• ·Weighted-average shares used in EPS calculation: 327,543,855 for Q1 2026 (up from 291,996,562 in Q1 2025).
• ·Issuance of 15,000,000 common shares for capital raises, net proceeds $20,721 thousand; 10,000,000 shares upon warrant exercises, proceeds $14,175 thousand.
• ·Property and equipment, net decreased to $13,830 thousand from $14,392 thousand QoQ.

08-05-2026

Gran Tierra Energy Inc. reported Q1 2026 revenue of $172,057 up 2.4% YoY from $168,173, driven by Ecuador sales surging 94% to $40,745 while Colombia declined 13% to $102,324 and Canada was flat down 1.7%; cash from operations strongly increased 136% YoY to $172,734. However, net loss widened dramatically to $119,172 from $19,280 YoY due to $77,328 unrealized derivative losses, higher interest expense of $49,878, and elevated G&A of $34,825, causing shareholders' equity to drop 52% QoQ to $108,920 from $228,744 despite long-term debt reduction to $574,354 from $686,521. Total assets edged up 3.1% QoQ to $1,635,080 with cash rising 50% to $124,752.

• ·Capex declined 38% YoY to $41,540 from $67,504 with sharp drops in Ecuador (-77%) and Canada (-33%).
• ·Current liabilities rose 53% QoQ to $544,053 driven by higher accounts payable $402,126 and derivatives $76,891.
• ·Segmented earnings in Ecuador up 88% YoY to $22,239; Canada up 5% to $13,356.

08-05-2026

For Q1 2026 ended March 31, 2026, Fortinet reported total revenue of $1,849.6 million, up 20.1% YoY from $1,539.7 million, with product revenue surging 40.5% to $645.1 million and service revenue growing 11.5% to $1,204.5 million; net income increased 23.3% to $534.5 million. Operating income rose 27.9% YoY to $580.0 million amid higher gross profit of $1,485.1 million. However, cash and cash equivalents declined $271.5 million QoQ to $2,223.8 million due to $823.0 million in stock repurchases and $500.0 million debt repayment, resulting in total assets dropping 4.9% QoQ to $9,883.5 million and stockholders' equity falling 20.0% to $989.7 million.

• ·Net cash provided by operating activities increased 24.7% YoY to $1,077.1 million.
• ·Deferred revenue rose to $3,726.3 million current and $3,625.2 million non-current as of March 31, 2026.
• ·Stock-based compensation expense was $72.5 million in Q1 2026, up from $66.1 million YoY.
• ·Weighted-average diluted shares outstanding decreased to 742.8 million from 776.8 million YoY.